Micromedex NeoFax Reference Reviews
Published by Merative on 2025-02-07🏷️ About: The support of this app will be discontinued on May 20, 2025. Visit the App Store to download the new Micromedex mobile app https://apps.
Is Micromedex NeoFax Reference Safe to Use?
We Investigate the app owner's website (Merative.com), verify their legitimacy, and uncover hidden scams and complaints.
Read 0 Customer Service Reviews 😠💢
5.0 out of 5
How was your experience with Micromedex NeoFax Reference? Post a Review
Features
Do you work at a facility that subscribes to Merative Micromedex® NeoFax®? Check with your Head of Pediatrics, Director of Pediatrics, Director of the NICU, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
Micromedex NeoFax Reference app is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Merative Micromedex for almost 40 years.
Micromedex NeoFax Reference drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
If you work at a facility that subscribes to Merative Micromedex® NeoFax® you may obtain free access to this app with your Micromedex NeoFax Reference password.
Micromedex NeoFax Reference allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population.
Contact Support
Developer:
Merative
